Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Changes in the T-lymphocytes (CD3+CD19-) and activated Tlymphocytes (CD3+HLA-DR+) in patients over 60 with mediterranean spotted fever

Margarita Gospodinova

. 2011 ; 2011 (2) : 31-35.

Language English Country Czech Republic Media elektronický zdroj

Persistent link   https://www.medvik.cz/link/bmc14045964

Mediterranean spotted fever (MSF) in Bulgaria shows increasing severity, especially in patients over sixty years. As T lymphocytes are the primary effector cells in MSF and are altered by the ageing process we aimed to specify the changes in their numbers in elderly patients. We performed a clinicoepidemiological study, haematological and biochemical analysis of 132 patients of 60+ and 30 patients between 19 and 57 years with MSF. We investigated the cell immunity of 20 patients of 60+ using immunofluocytometry. The control group consisted of 10 younger patients and 10 healthy individuals of 60+. MSF showed more unfavourable course in the elderly.We found T-lymphocytes depletion in all patients with MSF. Activated T lymphocytes were increased in elderly patients with MSF. We found significant differences between the number of activated T lymphocytes in elderly patients and healthy elderly persons. The observed T-lymphocytes depletion in MSF corresponded to the disease severity. The increase in the activated T lymphocytes in patients over 60 years contributes to an adequate immune response.

Changes in the T-lymphocytes (CD3+CD19-) and activated Tlymphocytes (CD3+HLA-DR+) in patients over 60 with mediterranean spotted fever [elektronický zdroj] /

References provided by Crossref.org

Bibliography, etc.

Literatura

000      
00000naa a2200000 a 4500
001      
bmc14045964
003      
CZ-PrNML
005      
20141031113010.0
007      
cr|cn|
008      
140214s2011 xr d fs 000 0eng||
009      
eAR
024    7_
$a 10.12955/emhpj.v2i0.340 $2 doi
040    __
$a ABA008 $d ABA008 $e AACR2 $b cze
041    0_
$a eng
044    __
$a xr
100    1_
$a Gospodinova, Margarita $u Medical University of Varna, Bulgaria
245    10
$a Changes in the T-lymphocytes (CD3+CD19-) and activated Tlymphocytes (CD3+HLA-DR+) in patients over 60 with mediterranean spotted fever $h [elektronický zdroj] / $c Margarita Gospodinova
504    __
$a Literatura
520    9_
$a Mediterranean spotted fever (MSF) in Bulgaria shows increasing severity, especially in patients over sixty years. As T lymphocytes are the primary effector cells in MSF and are altered by the ageing process we aimed to specify the changes in their numbers in elderly patients. We performed a clinicoepidemiological study, haematological and biochemical analysis of 132 patients of 60+ and 30 patients between 19 and 57 years with MSF. We investigated the cell immunity of 20 patients of 60+ using immunofluocytometry. The control group consisted of 10 younger patients and 10 healthy individuals of 60+. MSF showed more unfavourable course in the elderly.We found T-lymphocytes depletion in all patients with MSF. Activated T lymphocytes were increased in elderly patients with MSF. We found significant differences between the number of activated T lymphocytes in elderly patients and healthy elderly persons. The observed T-lymphocytes depletion in MSF corresponded to the disease severity. The increase in the activated T lymphocytes in patients over 60 years contributes to an adequate immune response.
650    12
$a marseillská horečka $x metabolismus $x patofyziologie $7 D001907
650    _2
$a imunitní systém $x fyziologie $7 D007107
650    12
$a antigeny CD3 $x fyziologie $7 D017252
650    12
$a buněčná imunita $7 D007111
650    _2
$a CD antigeny $x fyziologie $x metabolismus $7 D015703
650    12
$a T-lymfocyty $x fyziologie $x metabolismus $7 D013601
650    _2
$a HLA-DR antigeny $7 D006684
650    _2
$a rickettsiové infekce $x diagnóza $7 D012282
650    _2
$a statistika jako téma $7 D013223
650    _2
$a dospělí $7 D000328
650    _2
$a lidé $7 D006801
650    _2
$a lidé středního věku $7 D008875
650    _2
$a mladý dospělý $7 D055815
773    0_
$t European medical, health and pharmaceutical journal $x 1804-5804 $g Roč. 2011, č. 2 (2011), s. 31-35 $w MED00177703
856    41
$u https://ojs.journals.cz/index.php/EMHPJ/issue/view/43 $y plný text volně přístupný
910    __
$a ABA008 $y 4 $z 0
990    __
$a 20140213090030 $b ABA008
991    __
$a 20141031113015 $b ABA008
999    __
$a ok $b bmc $g 1012958 $s 844498
BAS    __
$a 3 $a 4 $a PRD
BMC    __
$a 2011 $b 2011 $c 2 $d 31-35 $i 1804-5804 $m European Medical, Health and Pharmaceutical Journal $n Eur. Med. Health Pharm. J. $x MED00177703
LZP    __
$c NLK183 $d 20140320 $a NLK 2014-12/vt

Find record

Citation metrics

Logged in users only

Archiving options